Please login to the form below

Not currently logged in
Email:
Password:

American Heart Association

This page shows the latest American Heart Association news and features for those working in and with pharma, biotech and healthcare.

Novartis launches heart failure social network

Novartis launches heart failure social network

To that end the company worked with several US health advocacy organisations to set up Together in HF, among them the American Association of Heart Failure Nurses, CardioSmart by the American ... College of Cardiology and WomenHeart: The National

Latest news

  • Amgen's Repatha unclogs blocked arteries, says study Amgen's Repatha unclogs blocked arteries, says study

    At the American Heart Association (AHA) annual meeting this week, lead study author Stephen Nichols of the University of Adelaide in Australia reported that adding a monthly Repatha shot to daily ... The results have also been published in the Journal of

  • Heart failure drug Entresto 'could save 28,000 lives a year' Heart failure drug Entresto 'could save 28,000 lives a year'

    Giving Novartis' Entresto to every eligible patient in the US would prevent or postpone almost 10% of heart failure-related deaths every year, according to a new study. ... All told, heart failure contributes to around 300, 000 deaths in the US every

  • An apple a day? An apple a day?

    At the recent American Heart Association's (AHA) Epidemiology/Lifestyle 2016 Scientific Sessions, two abstracts caught my eye. ... Specifically, heart attacks could decrease by 2.6% and strokes by 4% over the 20-year period.

  • Genzyme opts into gene silencing therapy for haemophilia Genzyme opts into gene silencing therapy for haemophilia

    Additional data from the phase I study will be reported later this year, most likely at the American Heart Association (AHA) in December.

  • Cholesterol drugs could have striking benefits in stroke Cholesterol drugs could have striking benefits in stroke

    Last year NICE issued new guidance recommending more people in the UK at risk of heart disease should be taking a statin, such as AstraZeneca's Crestor (rosuvastatin) – pictured above. ... This followed 2013 guidelines from the American Heart

More from news
Approximately 2 fully matching, plus 33 partially matching documents found.

Latest from PMHub

  • American Heart Association

    American Heart Association. We produced this animated short for the American Heart Association to illustrate the stories of 3 young heroes who each have remarkable stories to tell of their quick ... thinking. AHA’ s innovative scheme has affected

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Creative Medical Research

Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...

Latest intelligence

image 1
Redefining communications excellence
How to be heard in today’s multichannel, multistakeholder, multimedia world...
AZ Campus
AstraZeneca: building a new ‘open innovation’ pharma company
The construction of its new HQ has suffered some serious delays, but new R&D and commercial success are lifting AstraZeneca’s prospects...
Erik Nordkamp
In conversation with Pfizer’s Erik Nordkamp
Pfizer’s UK general manager talks to PME about the NHS at 70, the potential of pharma partnerships and some lessons from Europe...

Infographics